Each article is made available under the terms of the . ​All of our articles are available to download individually in PDF format.


Time To Control Gout and Make It Crystal Clear

Time To Control Gout and Make It Crystal Clear

November 20, 2017 at 8:30 AM 0 comments

This symposium took place on 15th June 2017, as part of the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology 2017 in Madrid, Spain Chairpersons: Fernando Perez-Ruiz,1 Thomas Bardin,2 Alexander So3 Speakers: Till Uhlig,4 Thomas Bardin,2 Pascal Richette,2 Alexander So,3 Fernando Perez-Ruiz1 1. Basque Country University, Baracaldo, SpainRead More

Biosimilars and Switching: What is Your Perspective?

Biosimilars and Switching: What is Your Perspective?

August 1, 2017 at 8:29 AM 0 comments

This satellite symposium took place on 16th June 2017 as a part of the European League Against Rheumatism (EULAR) Congress in Madrid, Spain Chairperson: John Isaacs1 Speakers: John Isaacs,1 Guro Løvik Goll,2 João Gonçalves,3 Ailsa Bosworth4 1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK 2. Department ofRead More

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

August 1, 2017 at 8:28 AM 0 comments

This symposium took place on 16th June as part of the European League Against Rheumatism (EULAR) Congress 2017 in Madrid, Spain Moderator: Chris Edwards1 Faculty: Merete Lund Hetland,2 Lars Erik Kristensen,2,3 Maria Cuadrado4 1. University of Southampton, Southampton, UK 2. University of Copenhagen, Copenhagen, Denmark 3. Lund University, Lund, SwedenRead More

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?

August 1, 2017 at 8:27 AM 0 comments

This symposium took place on 16th June 2017 as a part of the European League Against Rheumatism (EULAR) Congress in Madrid, Spain Speakers: Juan Gomez-Reino,1 Ana-Maria Orbai,2 Laure Gossec3 1. Hospital Clinico Universitario de Santiago, La Coruña, Spain 2. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 3. Sorbonne Universités, UPMCRead More

Editor’s Pick: Why Do Diseases Start One Sided? Clues from HLA-B27 Acute Anterior Uveitis

Editor’s Pick: Why Do Diseases Start One Sided? Clues from HLA-B27 Acute Anterior Uveitis

August 1, 2017 at 8:26 AM 0 comments

In this intriguing article, Margo S. Clarke explores the fascinating topic of disease left–right asymmetry, putting HLA-B27 acute anterior uveitis under the spotlight. She explores the immune system’s exquisite selective ability to react to molecular variance and prompts further discussion on how a deeper understanding of lateralisation could impact theRead More

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

August 1, 2017 at 8:25 AM 0 comments

*Boel De Paepe Neuromuscular Reference Center & Department of Neurology, Ghent University Hospital, Ghent, Belgium *Correspondence to boel.depaepe@ugent.be Disclosure: The author has declared no conflicts of interest. Acknowledgements: The author is the recipient of a research grant from the Association Belge contre les Maladies neuro-Musculaires (ABMM), Aide à la RechercheRead More

Advances in Epigenetics and Integration of Omics in Lupus

Advances in Epigenetics and Integration of Omics in Lupus

August 1, 2017 at 8:24 AM 0 comments

*Joyce S. Hui-Yuen,1 Suhas K. Ganguli,1 James N. Jarvis2 1. Cohen Children’s Medical Center, Northwell Health and Hofstra-Northwell School of Medicine, New Hyde Park, New York, USA 2. Department of Pediatrics and Genetics, Genomics, & Bioinformatics Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USARead More

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

August 1, 2017 at 8:23 AM 0 comments

*Bruno Sarmento,1,2 Marco Sarmento3,4 1. Instituto de Investigação e Inovação em Saúde (i3S) and Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto, Portugal 2. Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde (CESPU) Instituto Universitário de Ciências da Saúde, Porto, Portugal 3. Faculdade de Medicina Universidade deRead More

Vitamin D Deficiency and Chronic Widespread Pain

Vitamin D Deficiency and Chronic Widespread Pain

August 1, 2017 at 8:22 AM 0 comments

*Ramazan Yilmaz, Serap Ozkayit Department of Physical Medicine and Rehabilitation, Yoncali Physical Medicine and Rehabilitation Hospital, Kutahya, Turkey *Correspondence to drramazanyilmaz@yahoo.com Disclosure: The authors have declared no conflicts of interest. Received: 10.04.17 Accepted: 21.06.17 Citation: EMJ Rheumatol. 2017;4[1]:104-111. Abstract Vitamin D acts as a steroid hormone possessing important functions inRead More

New Drug Treatments for Osteoarthritis: What is on the Horizon?

New Drug Treatments for Osteoarthritis: What is on the Horizon?

March 2, 2017 at 8:24 AM 0 comments

*Fiona E. Watt,1 Malvika Gulati2 1. Arthritis Research UK Centre for Osteoarthritis Pathogenesis, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK 2. Department of Rheumatology, Royal Free Hospital, London, UK *Correspondence to fiona.watt@kennedy.ox.ac.uk Disclosure: The authors have declared no conflicts of interest. Support:Read More